Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Garen Bohlin joins Constellation Pharmaceuticals

This article was originally published in Scrip

Executive Summary

Constellation Pharmaceuticals (US) has named Garen Bohlin executive vice-president; he will be responsible for the company's corporate operations and finance. He most recently served as chief operating officer of Sirtris Pharmaceuticals, where he also played a key role in the sale of the company to GlaxoSmithKline for more than $720 million (, June 13th, 2008). Before that, Mr Bohlin was the founding chief executive officer of Syntonix Pharmaceuticals, which was consequently sold to Biogen Idec in 2007.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts